ImmunityBio to serve as sole U.S. Biologics License Application applicant for the Tokyo strain of BCG and plans to engage with U.S. Food and Drug Administration (FDA) on regulatory pathway to address ...
Chan of Marin Health UCSF Health Clinic, in collaboration with Dr. Kymora Scotland and colleagues from UCLA, presented a ...
David Matheson discusses the patient perspective on radiographic progression-free survival as a clinical trial endpoint. Dr. Matheson argues that imaging-based progression is more ...
Tyler Seibert outlines his approach to radiation therapy for the primary tumor in metastatic hormone-sensitive prostate cancer. He summarizes three randomized trials that consiste ...
Also previously reported, there was no benefit for extended pelvic lymphadenectomy in the overall cohort for metastasis free ...
The NCCN Guidelines for Prostate Cancer provide a framework on which to base decisions for patients with prostate cancer across the disease spectrum. The Guidelines sections included in this article ...
Matthew Cooperberg speaks with Martin Gleave about GUNS, a neoadjuvant adaptive umbrella trial for men with high-volume, high-grade prostate cancer. Now at 280 patients enrolled, GUNS sequences needle ...
Alicia Morgans: I am going to be talking about incorporating PSMA PETs into registration trials with an example of a study that is relying on a PSMA PET endpoint as the primary endpoint in the study.
Development of a Risk Predictive Model for Erectile Dysfunction at 12 Months after COVID-19 Recovery: A Prospective Observational Study - Beyond the Abstract ...
Chronic prostatitis/chronic pelvic pain syndrome: Interplay of inflammatory mediators, "Beyond the Abstract," by Dan Lundh, Hans Hedelin, and Dennis Larsson ...
Inherited Defects of piRNA Biogenesis Cause Transposon De-Repression, Impaired Spermatogenesis, and Human Male Infertility - Beyond the Abstract ...
Bladder Cancer - Read the latest Bladder Cancer research including Full-Text Abstracts as well as "Beyond the Abstract" articles, written by the researchers exclusively for UroToday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results